Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Details Narrative)

v3.21.1
Stock-based Compensation (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Oct. 06, 2020
Aug. 05, 2020
Aug. 29, 2019
Jun. 20, 2019
Dec. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Jun. 19, 2019
Number of stock award granted to employees and directors           343,110    
Number of stock awards vested in period           214,078    
Number of stock awards unvested         129,032 129,032  
Number of stock awards issued           343,110    
Number of stock option granted           129,919  
Stock option contractual term           6 years 1 month 27 days 5 years 9 months 18 days  
Stock option, exercise price         $ 17.92 $ 17.92    
Fair value per share, weighted average             $ 9.88  
Aggregate fair value of the stock options vested           921,227 415,313  
Number of stock option exercised            
Employees and Directors [Member]                
Number of stock option granted       129,919        
Stock option contractual term       5 years        
Stock option, exercise price       $ 16.80        
Employees [Member] | Tranche One [Member] | Service Vesting [Member]                
Number of stock option granted       65,148        
Stock option contractual term       3 years        
Employees [Member] | Tranche Two [Member] | In-license an Additional Drug Asset [Member]                
Number of stock options vested     12,958          
Employees [Member] | Phase 2A Clinical Trial for PCS-499 [Member] | Tranche Two [Member]                
Number of stock options vested           12,958    
Employees [Member] | Up-Listed From The OCTQB [Member] | Tranche Two [Member]                
Number of stock options vested           38,855    
Performance Vesting [Member] | Employees [Member] | Tranche Two [Member]                
Number of stock option granted       64,771        
2019 Plan [Member]                
Number of shares available for issuance               500,000
2019 Plan [Member] | Unvested Stock Options and Restricted Stock [Member]                
Unrecognized compensation expense         $ 1,426,301 $ 1,426,301    
Weighted average period           2 years 6 months 10 days    
2019 Omnibus Incentive Plan [Member] | Restricted Stock Award [Member]                
Number of stock awards outstanding         319,306 319,306    
2019 Omnibus Incentive Plan [Member] | Restricted Stock Award [Member] | Employees and Directors [Member]                
Number of stock award granted to employees and directors   324,360       343,110    
Number of stock awards vested in period 214,078              
2019 Omnibus Incentive Plan [Member] | Restricted Stock Award [Member] | Employees and Directors [Member] | First and Second Year Anniversary [Member]                
Number of stock awards unvested         110,282 110,282    
2019 Omnibus Incentive Plan [Member] | Restricted Stock Award [Member] | Employees [Member]                
Number of stock awards forfeited period 23,804              
2019 Omnibus Incentive Plan [Member] | Restricted Stock Award [Member] | Chief Operational Officer [Member]                
Number of stock awards issued         12,500      
2019 Omnibus Incentive Plan [Member] | Restricted Stock Award [Member] | Senior Director [Member]                
Number of stock awards issued         6,250